20096 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Pyrrolidone derivatives for use as MetAP-2 inhibitors
#3302Pharmaceutical Composition of Lyophilized Formulation and Preparation Method of the Same
#3303Thrombin-like enzyme of
#3304Therapeutic formulation for reduced drug side effects
#3305VEGF antagonist formulations for intravitreal administration
#3306Stabilized statin formulations
#3307Pharmaceutical formulations comprising voriconazole and processes for preparation thereof
#3308Pyridazinone derivatives
#3309COMPOSITIONS FOR DRUG ADMINISTRATION
#3310Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same
#3311PHOSPHOLIPID MICELLAR AND LIPOSOMAL COMPOSITIONS AND USES THEREOF
#3312PREPARATION METHOD OF POLYMERIC MICELLES COMPOSITION CONTAINING A POORLY WATER-SOLUBLE DRUG
#3313SUSTAINED RELEASE NITRIC OXIDE FROM LONG LIVED CIRCULATING NANOPARTICLES
#3314Injectable formulations of taxanes for cad treatment
#3315APO-2 ligand/trail formulations
#3316POLYUNSATURATED FATTY ACIDS FOR IMPROVING VISION
#3317DISPERSIBLE PHOSPHOLIPID STABILIZED MICROPARTICLES
#3318COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#3319Compositions and Methods for Treating Collagen-Mediated Diseases
#3320Compositions and Methods for Treating Collagen-Mediated Diseases
#3321Compositions and Methods for Treating Collagen-Mediated Diseases
#3322FORMULATIONS AND METHODS OF USE
#3323Process for forming amorphous atorvastatin
#3324Stabilized glucagon solutions
#3325Protein stabilization formulations
#3326Antibody Formulation
#3327Vinyl alcohol co-polymer cryogels, vinyl alcohol co-polymers, and methods and products thereof
#3328USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION OF STROKE OR TRANSIENT ISCHEMIC ATTACK
#3329Stable bortezomib formulations
#3330Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
#3331Lyophilized formulations of engineered anti-IL-23p19 antibodies
#3332Stabilized liquid and lyophilized ADAMTS13 formulations
#3333Buffers for Controlling the pH of Bone Morphogenetic Proteins
#3334Lyophilized Cake Formulations
#3335Formulations of canfosfamide and their preparation
#3336Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
#3337Therapeutic/prophylactic agent for prostate cancer
#3338Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides
#3339METHODS AND COMPOSITIONS FOR DELIVERY OF EXOGENOUS FACTORS TO NERVIOUS SYSTEM SITES
#3340STABILIZED PENTOSAN POLYSULFATE (PPS) FORMULATIONS AND METHODS OF ANALYZING THEM
#3341METHOD FOR PRODUCING POWDER CONTAINING NANOPARTICULATED SPARINGLY SOLUBLE DRUG, POWDER PRODUCED THEREBY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME (As Amended)
#3342COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC DISEASES
#3343PHARMACEUTICAL FORMULATIONS COMPRISING PEMETREXED
#3344FREEZE-DRIED REPARATION OF TETRODOTOXIN AND THE PRODUCING METHOD THEREOF
#3345MAGNETICALLY SENSITIVE DRUG CARRIERS FOR TREATMENT OR TARGETED DELIVERY
#3346COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY
#3347PROSAPOSIN AS A NEUROTROPHIC FACTOR
#3348Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid
#3349NANOPARTICLE COMPOSITIONS COMPRISING LIQUID OIL CORES
#3350PHARMACEUTICAL COMPOSITION CONTAINING SURFACE-COATED MICROPARTICLES
#3351Compositions and Methods for Treating Collagen-Mediated Diseases
#3352Compositions and Methods for Treating Collagen-Mediated Diseases
#3353Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#3354POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
#3355Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity
#3356Multi-unit gastroretentive pharmaceutical dosage form comprising microparticles
#3357Highly compression resistant matrix with porous skeleton
#3358Alphavirus and alphavirus replicon particle formulations and methods
#3359PHARMACEUTICAL COMPOSITIONS COMPRISING BORONIC ACID COMPOUNDS
#3360NEW PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIII
#3361PHARMACEUTICAL COMPOSITIONS OF [5(S)-(2'-HYDROXYETHOXY)-20(S)-CAMPTOTHECIN
#3362Compositions for Controlled Delivery of Pharmaceutically Active Compounds
#3363WOUND HEALING
#3364COMPOSITION FOR CRYOPRESERVATION OF CELLS AND TISSUES
#3365PROCESS FOR PREPARING A CARBAPENEM ANTIBIOTIC COMPOSITION
#3366Oral recombinant vaccine and preparing method thereof
#3367Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system
#3368Absorption of therapeutic agents across mucosal membranes or the skin
#3369POLYMERIC DELIVERY SYSTEMS FOR ACTIVE AGENTS
#3370Dry transglutaminase composition
#3371Co-solvent compositions and methods for improved delivery of dantrolene therapeutic agents
#3372STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES
#3373COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#3374RAPID RECONSTITUTION FOR LYOPHILIZED-PHARMACEUTICAL SUSPENSIONS
#3375Thermal shielding to optimize lyophilization process for pre-filled syringes or vials
#3376Pharmaceutical compositions containing botulinum toxin
#3377Treatment of inflammatory bowel disease using glucagon-like-peptide-2 (GLP-2) analogues
#3378COMPOSITIONS COMPRISING POORLY WATER SOLUBLE PHARMACEUTICAL AGENTS AND ANTIMICROBIAL AGENTS
#3379Frozen compositions and methods for piercing a substrate
#3380Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
#3381Analgesic Apatitic Calcium-Phosphate Cement
#3382Nanoparticles for protein drug delivery
#3383Nanoparticles for protein drug delivery
#3384NANOPARTICLES OF CHITOSAN AND HYALURONAN FOR THE ADMINISTRATION OF ACTIVE MOLECULES
#3385Sustained-release composition and method for producing the same
#3386ANTIBODIES WITH DECREASED DEAMIDATION PROFILES
#3387Organic Compounds
#3388FORMULATIONS OF DAPTOMYCIN
#3389COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY
#3390Tigecycline compositions and methods of preparation
#3391Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#3392Storage-stable, functionally intact fibrinogen
#3393Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
#3394Methods of treating or preventing stent thrombosis
#3395METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND DECREASING THE ABSORPTION VARIABILITY OF ORALLY ADMINISTERED DRUGS, VITAMINS AND NUTRIENTS
#3396CELL FUSION PROMOTER AND UTILIZATION OF THE SAME
#3397Cross-linked compositions
#3398METHODS OF SYNTHESIS AND USE OF CHEMOSPHERES
#3399Method and device for continuously preparing microspheres, and collection unit thereof
#3400Cellulose interpolymers and methods of oxidation
#3401Glucagon-like-peptide-2 (GLP-2) analogues
#3402Desiccated biologics and methods of preparing the same
#3403STABILIZED GLUCAGON SOLUTIONS
#3404FORMULATION FOR PREVENTING OR REDUCING BLEEDING AT A SURGICAL SITE
#3405Oral formulations of cladribine
#3406Polyporous hollow bone screw
#3407Azide functionalized peptide targeting groups
#3408METHOD FOR TREATING/PREVENTING DISEASE USING COGNITIVE ABILITY OF CEREBRUM AND PHARMACEUTICAL
#3409Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications
#3410Compositions comprising polymeric micelles for drug delivery
#3411Therapeutic composition with a botulinum neurotoxin
#3412Prophylactic and therapeutic treatment of neuro-degenerative diseases and protein aggregation diseases
#3413Hydroxyethyl Starch-Containing Polypeptide Compositions
#3414Stabilized compositions of proteins having a free thiol moeity
#3415Methods and compositions for tissue regeneration
#3416Compositions for delivering highly water soluble drugs
#3417RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
#3418Highly Concentrated Pharmaceutical Formulations
#3419Producing a sustained-release preparation
#3420Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance
#3421Methods for the preparation of liposomes comprising docetaxel
#3422Methods for the Administration of Drugs Using Liposomes
#3423Methods for the Preparation of Liposomes Comprising Docetaxel
#3424Methods for the preparation of liposomes
#3425Beta antibody parenteral formulation
#3426Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
#3427Drug Delivery System, its Preparation Process and Use
#3428METHODS FOR PRODUCING BLOCK COPOLYMER/AMPHIPHILIC PARTICLES
#3429Intracutaneous paste composition
#3430Methods for drug delivery comprising unfolding and folding proteins and peptide nanoparticles
#3431Tannin-chitosan composites
#3432METHOD OF PURIFYING APO-2 LIGAND/TRAIL USIN CRYSTALLISATION THE COLD
#3433Slow release pharmaceutical composition made of microgranules
#3434Hemostatic Sponge with Enzyme and Method of Manufacture
#3435Non-Aggregating Virus Formulation
#3436Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix
#3437Pharmaceutical compositions containing toxoids A and B
#3438Subcutaneous anti-HER2 antibody formulations and uses thereof
#3439FORMULATIONS OF AZACITIDINE AND ITS DERIVATIVES
#3440Liquid and Freeze Dried Formulations
#3441Stabilisation of Proteins
#3442Polymer formulations for delivery of bioactive agents
#3443Ophthalmic drug delivery system containing phospholipid and cholesterol
#3444OLIGONUCLEOTIDES-TRANSFERRING PREPARATIONS
#3445Desiccated Biologics And Methods Of Preparing The Same
#3446Oligo-Ethylene Glycol-Based Polymer Compositions and Methods of Use
#3447Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds
#3448Nouvelle forme d'administration de proteines osteogeniques
#3449PLATFORM ANTIBODY COMPOSITIONS
#3450Compositions Containing Cyclic Peptides And Methods Of Use
#3451LYOPHILIZED PREPARATION OF STABILIZED ANTHRACYCLINE COMPOUNDS
#3452Stabilizing alkylglycoside compositions and methods thereof
#3453Compositions and methods for microbe storage and delivery
#3454Use of oligomers of lactic acid in the treatment of gynaecological disorders
#3455Method for lyophilising particles having a pharmaceutical compound contained therein and a pharmaceutical pack containing such particles
#3456STABLE PHARMACEUTICAL AQUEOUS COMPOSITIONS
#3457Lyophilized nanoemulsion
#3458CO-SOLVENT COMPOSITIONS AND METHODS FOR IMPROVED DELIVERY OF DANTROLENE THERAPUTIC AGENTS
#3459Compositions comprising dehydrated micro-organisms, method for preparing same, and uses thereof
#3460Stable formulations of thiadiazole derivative
#3461SOLUBILITY-ENHANCED FORMS OF APREPITANT AND PHARMACEUTICAL COMPOSITIONS THEREOF
#3462Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids
#3463Recombinant elastase proteins and methods of manufacturing and use thereof
#3464Microparticle and pharmaceutical composition thereof
#3465LYOPHILIZED PHARMACEUTICAL COMPOSITIONS
#3466Processes of making pharmaceutical formulations of antineoplastic agents
#3467PRESERVING SECONDARY PEPTIDE STRUCTURE
#3468Spray freeze dry of compositions for pulmonary administration
#3469Albumin-free botulinum toxin formulations
#3470COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#3471Inhalable solid amorphous particles comprising tiotropium bromide and a co-solid
#3472SYN3 compositions and methods
#3473STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE
#3474Method for protection of peptides or proteins against non-enzymatic deamidation
#3475Pharmaceutical formulations
#3476Oral formulations of bis(thiohydrazide amides)
#3477Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
#3478Synthesis of -methylnaltrexone
#3479SOLID DISPERSIONS CONTAINING AN APOPTOSIS-PROMOTING AGENT
#3480PHARMACEUTICAL COMPOSITIONS COMPRISING N-[2-(DIETHYLAMINO)ETHYL]-5-[(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE
#3481ORAL FORMULATIONS FOR PICOPLATIN
#3482Alpha-1-antitrypsin compositions
#3483LYOPHILIZED PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY CONTAINING TAXANE DERIVATIVES, AND METHOD OF MANUFACTURING THE SAME
#3484Pharmaceutical compositions and methods for the treatment of prostate cancer
#3485Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative
#3486ORAL DELIVERY OF PROTEINS AND PEPTIDES
#3487Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
#3488Pharmaceutical formulations
#3489PHARMACEUTICAL FORMULATION CONTAINING RECOMBINANT HUMAN SERUM ALBUMIN-INTERFERON ALPHA FUSION PROTEIN
#3490Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#3491Antitumor agent
#3492INSULIN NASAL POWDER INHALATION
#3493Compositions of phytosterols with enhanced bioavailability
#3494PHARMACEUTICAL COMPOSITION FOR THE SUBLINGUAL ADMINISTRATION OF VACCINES, METHOD FOR THE PREPARATION OF THE SAME AND USES THEREOF
#3495Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions
#3496Antibiotic formulations, unit doses, kits and methods
#3497MENINGOCOCCAL VACCINE FORMULATIONS
#3498VEGF antagonist formulations
#3499ANTIBODY FORMULATIONS HAVING OPTIMIZED AGGREGATION AND FRAGMENTATION PROFILES
#3500Cartilage particle tissue mixtures optionally combined with a cancellous construct
#3501Formulations and methods for lyophilization and lyophilates provided thereby
#3502SOLID PHARMACEUTICAL COMPOSITION CONTAINING SOLIFENACIN AMORPHOUS FORM
#3503Freeze-dried composition of active substances
#3504SUPPLEMENTARY FOOD COMPOSITION FOR REDUCING BODY ODOR
#3505NANOCELL DRUG DELIVERY SYSTEM
#3506Freeze-Dried Coated Molded Article
#3507VACCINES FOR MALARIA
#3508LYOPHILIZED PHARMACEUTICAL COMPOSITION WITH IMPROVED RECONSTITUTION TIME CONTAINING TAXANE DERIVATIVES AND METHOD OF MANUFACTURING THE SAME
#3509PHARMACEUTICAL FORMULATION
#3510Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispensing agent and method for the preparation thereof
#3511PHARMACEUTICAL FORMULATION
#3512PHARMACEUTICAL FORMULATION
#3513Stable methylnaltrexone preparation
#3514Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
#3515Liposomal Formulations of Tocopheryl Amides
#3516Crystalline forms of a biphenyl compound
#3517Pharmaceutical powder compositions
#3518PHARMACEUTICAL FORMULATION OF TAXANE
#3519STABILIZED PHARMACEUTICAL COMPOSITION
#3520Stable pharmaceutical composition of freeze-dried tetrodoxin powder
#3521Prophylactic and therapeutic treatment of Alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein
#3522POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
#3523POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
#3524Microspheres
#3525Pharmaceutical compositions comprising hGH for oral delivery
#3526CARRIER SYSTEM FOR BIOLOGICAL AGENTS CONTAINING ORGANOSILICON COMPOUNDS AND USES THEREOF
#3527Stabilization of vaccines by lyophilization
#3528Drug delivery system for hydrophobic drugs
#3529COMPOSITIONS CONTAINING OPIOID ANTAGONISTS
#3530SUSTAINED RELEASE OF MICROCRYSTALLINE PEPTIDE SUSPENSIONS
#3531Pyridazinone derivatives
#3532STABILIZED MICRONISED PARTICLES
#3533Polymeric delivery formulations of leuprolide with improved efficacy
#3534Freeze-dried plasma formats for the trauma care field
#3535USE OF CRYOGENIC PROCESSING TO OBTAIN A SUBSTANTIALLY-THICKENED FORMULATION
#3536LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS
#3537COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#3538REDUCTION OF ADIPOSE TISSUE
#3539Compositions and methods of delivery of pharmacological agents
#3540Polymeric delivery formulations of leuprolide with improved efficacy
#3541Lyophilised Antibody Formulation
#3542MEDICINAL FORMS OF PHOSPHOLIPID PREPARATIONS AND METHODS FOR THEIR PREPARATION
#3543Bendamustine cyclopolysaccharide compositions
#3544STABILIZED PICOPLATIN DOSAGE FORM
#3545METHODS OF TREATMENT USING INTRAVENOUS FORMULATIONS COMPRISING TEMOZOLOMIDE
#3546Oral administration of a calcitonin
#3547Stabilizing alkylglycoside compositions and methods thereof
#3548ANTIBODY FORMULATION
#3549Encapsulation and controlled release of small molecules for intracellular delivery using thermally responsive nanocapsules
#3550Pharmaceutical formulation
#3551COMPOSITIONS OF PEGYLATED SOLUBLE TUMOR NECROSIS FACTOR RECEPTORS AND METHODS OF PREPARING
#3552Kind of piperphentonamine hydrochloride lyophilized powder for injection and preparation and use thereof
#3553Pyrimidinyl pyridazinone derivatives
#3554Compositions and methods of delivery of pharmacological agents
#3555Methods for producing aripiprazole suspension and freeze-dried formulation
#3556Stable Non-Aqueous Pharmaceutical Compositions
#3557Ejaculum of animals as medicinal material and uses thereof in medicaments for treatment of diseases such as tumors, depression, etc
#3558Systems, devices, and methods for making or administering frozen particles
#3559Systems, devices, and methods for making or administering frozen particles
#3560Complex consisted of a polysaccharide and an HBP
#3561Hyperbranched polymers based on cyclodextrins and poly (amidoamines) for the controlled release of insoluble drugs
#3562Phosphoramidate alkylator prodrugs for the treatment of cancer
#3563Nanoparticle comprising rapamycin and albumin as anticancer agent
#3564Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
#3565Hemostatic compositions containing sterile thrombin
#3566Medicinal forms of phospholipid preparations and methods for their preparation
#3567COMBINATION THERAPY FOR OVARIAN CANCER
#3568Highly purified type A toxin preparation from infant botulism pathogen
#3569Controlled release implantable dispensing device and method
#3570PARTICLES FOR DELIVERY OF ACTIVE INGREDIENTS, PROCESS OF MAKING AND COMPOSITIONS THEREOF
#3571BIOCOMPATIBLE MICROGELS AND APPLICATIONS THEREOF
#3572Systems, devices, and methods for making or administering frozen particles
#3573Pharmaceutical formulation containing gelling agent
#3574Method of stabilizing S-adenosyl-L-methionine and stabilized composition
#3575FACTOR VIII FORMULATIONS
#3576Pharmaceutical Formulations and Methods for Making the Same
#3577Technology for Preparation of Macromolecular Microspheres
#3578Administration form of osteogenic protein complexes
#3579Anti A beta antibody formulation
#3580Systems, devices, and methods for making or administering frozen particles
#3581Treatment using dantrolene
#3582STABILIZED FREEZE-DRIED FORMULATION FOR CEPHALOSPORIN DERIVATIVES
#3583Glycopeptide phosphonate derivatives
#3584Method for stabilizing blood plasma components in a lyophilizate using carbon dioxide and phosphoric acid
#3585Polymeric micelles for drug delivery
#3586Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
#3587Formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or class II molecules for vaccine
#3588Stable polypeptide formulations
#3589METHODS OF TREATING IgE-MEDIATED DISORDERS COMPRISING THE ADMINISTRATION OF HIGH CONCENTRATION ANTI-IgE ANTIBODY FORMULATIONS
#3590MICROBUBBLES AS DRUG DELIVERY DEVICE
#3591Systems, devices and methods for making or administering frozen particles
#3592Frozen compositions and methods for piercing a substrate
#3593ANTIVIRAL AGENT
#3594Low-viscous anthracycline formulation
#3595Multiphase drug delivery system
#3596Lyophilization of Hemoglobin Solutions
#3597Stable Non-Aqueous Pharmaceutical Compositions
#3598Frozen compositions and methods for piercing a substrate
#3599Delivery devices for modulating inflammation
#3600Delivery devices for modulating inflammation